Journal list menu
Export Citations
Download PDFs
Editorial
no
Targeting the interleukin-15 system in rheumatoid arthritis
- Pages: 2585-2588
- First Published: 02 September 2005
no
Churg-Strauss syndrome: Just one disease entity?
- Pages: 2589-2593
- First Published: 02 September 2005
Review
no
Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation
- Pages: 2594-2598
- First Published: 02 September 2005
no
Protective autoantibodies: Role in homeostasis, clinical importance, and therapeutic potential
- Pages: 2599-2606
- First Published: 02 September 2005
Special Article
no
International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies†
- Pages: 2607-2615
- First Published: 02 September 2005
Research Article
no
Is the disease course of rheumatoid arthritis becoming milder?: Time trends since 1985 in an inception cohort of early rheumatoid arthritis
- Pages: 2616-2624
- First Published: 02 September 2005
Research Articles
no
Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states
- Pages: 2625-2636
- First Published: 02 September 2005
no
An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility
- Pages: 2637-2644
- First Published: 02 September 2005
no
Antigen microarray profiling of autoantibodies in rheumatoid arthritis
- Pages: 2645-2655
- First Published: 02 September 2005
no
RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via toll-like receptor 3
- Pages: 2656-2665
- First Published: 02 September 2005
no
Effectiveness of anti–folate receptor β antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages
- Pages: 2666-2675
- First Published: 02 September 2005
no
Dehydroascorbate transport in human chondrocytes is regulated by hypoxia and is a physiologically relevant source of ascorbic acid in the joint
- Pages: 2676-2685
- First Published: 02 September 2005
no
Targeting interleukin-15 in patients with rheumatoid arthritis: A proof-of-concept study
- Pages: 2686-2692
- First Published: 02 September 2005
no
Fcγ receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor α–blocking agents
- Pages: 2693-2696
- First Published: 02 September 2005
no
Butyrate suppresses tumor necrosis factor α production by regulating specific messenger RNA degradation mediated through a cis-acting AU-rich element
- Pages: 2697-2707
- First Published: 02 September 2005
no
Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2
- Pages: 2708-2718
- First Published: 02 September 2005
no
Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-κB activation
- Pages: 2719-2729
- First Published: 02 September 2005
no
Disruption of the interaction of T cells with antigen-presenting cells by the active leflunomide metabolite teriflunomide: Involvement of impaired integrin activation and immunologic synapse formation
- Pages: 2730-2739
- First Published: 02 September 2005
no
Rituximab treatment in patients with primary Sjögren's syndrome: An open-label phase II study†
- Pages: 2740-2750
- First Published: 02 September 2005
no
Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios
- Pages: 2751-2760
- First Published: 02 September 2005
no
Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus
- Pages: 2761-2767
- First Published: 02 September 2005
no
Maternal HLA class II compatibility in men with systemic lupus erythematosus
- Pages: 2768-2773
- First Published: 02 September 2005
no
Incidence and risk factors of thromboembolism in systemic lupus erythematosus: A comparison of three ethnic groups
- Pages: 2774-2782
- First Published: 02 September 2005
no
Cerebral and corpus callosum atrophy in systemic lupus erythematosus
- Pages: 2783-2789
- First Published: 02 September 2005
no
Selective expansion of a monocyte subset expressing the CD11c dendritic cell marker in the Yaa model of systemic lupus erythematosus
- Pages: 2790-2798
- First Published: 02 September 2005
no
The presence of molecular markers of in vivo lipid peroxidation in osteoarthritic cartilage: A pathogenic role in osteoarthritis
- Pages: 2799-2807
- First Published: 06 September 2005
no
Fasting serum sulfate levels before and after development of osteoarthritis in participants of the veterans administration normative aging longitudinal study do not differ from levels in participants in whom osteoarthritis did not develop
- Pages: 2808-2813
- First Published: 06 September 2005
no
Bone marrow lesions in the knee are associated with increased local bone density
- Pages: 2814-2821
- First Published: 06 September 2005
no
Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: A three-month longitudinal study
- Pages: 2822-2829
- First Published: 06 September 2005
no
The genetic contribution to longitudinal changes in knee structure and muscle strength: A sibpair study
- Pages: 2830-2834
- First Published: 06 September 2005
no
Secondary gait changes in patients with medial compartment knee osteoarthritis: Increased load at the ankle, knee, and hip during walking
- Pages: 2835-2844
- First Published: 06 September 2005
Research Article
no
Knee stabilization in patients with medial compartment knee osteoarthritis
- Pages: 2845-2853
- First Published: 02 September 2005
Research Articles
no
The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the disease activity core set
- Pages: 2854-2864
- First Published: 02 September 2005
no
Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: Introduction of the Dijkstra composite score
- Pages: 2865-2872
- First Published: 02 September 2005
no
Localized scleroderma in childhood is not just a skin disease
- Pages: 2873-2881
- First Published: 02 September 2005
no
Prevalence of Barrett's esophagus in systemic sclerosis
- Pages: 2882-2888
- First Published: 02 September 2005
no
Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: A sensitive indicator of active pulmonary fibrosis
- Pages: 2889-2896
- First Published: 02 September 2005
no
Involvement of αvβ5 integrin–mediated activation of latent transforming growth factor β1 in autocrine transforming growth factor β signaling in systemic sclerosis fibroblasts
- Pages: 2897-2905
- First Published: 02 September 2005
no
Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor–associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-κB activation
- Pages: 2906-2916
- First Published: 02 September 2005
no
Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus–associated mixed cryoglobulinemia vasculitis neuropathy
- Pages: 2917-2925
- First Published: 02 September 2005
no
Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome
- Pages: 2926-2935
- First Published: 02 September 2005
no
Innate immunity conferred by toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal–induced inflammation
- Pages: 2936-2946
- First Published: 02 September 2005
Concise Communications
no
Failure to confirm association between SLC22A4 polymorphism and rheumatoid arthritis in a Japanese population
- Pages: 2947-2948
- First Published: 02 September 2005
no
Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort
- Pages: 2948-2950
- First Published: 06 September 2005
no
Soluble complement receptor 1 (CD35) bound to immune complexes in sera of patients with systemic lupus erythematosus
- Pages: 2950-2951
- First Published: 06 September 2005
Errata
Free Access
free
Errata: Antoni C, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester G, Schneider U, Furst D, Molitor J, Keystone E, Gladman D, Manger B, Wassneberg S, Weier R, Wallace D, Weisman M, Kalden J, Smolen J. Sustained Benefits of Infliximab Therapy for Dermatologic and Articular Manifestations of Psoriatic Arthriti,Arthritis Rheum 2005 52(4)1227-36
- Page: 2951
- First Published: 02 September 2005
Free Access
free
Errata: Cron R. A Signal Achievement in the Treatment of Arthritis, Arthritis Rheum 2005 52(8)2229-32
- Page: 2951
- First Published: 02 September 2005
Letters
no
Heterogeneity of tumor necrosis factor receptor–associated periodic syndrome: Comment on the article by Siebert et al
- Page: 2952
- First Published: 02 September 2005
no
Chewing pads versus pachydermodactyly: Comment on the clinical image by Akikusa et al
- Page: 2953
- First Published: 02 September 2005
Clinical Images
no
Clinical images: Drumstick-like fingers indicating psoriatic onycho-pachydermo periostitis
- Page: 2954
- First Published: 02 September 2005